Cutting edge formulary and guideline intelligence in real-time


Understanding, monitoring and deciphering the ever-changing UK formulary and guideline landscape is a difficult and time-consuming challenge for your organisation, but it’s one Healthcare Business Information, an IQVIA business, has a wealth of experience solving.

Launched in 2015, Discovery Fx remains the UK’s first and only custom built interactive formulary and guideline analysis platform. Our Team have an unrivalled knowledge of formulary tracking, adherence, classification and analysis. We track and review UK wide formularies and guidelines in real-time, so you don’t have to.

We understand that formulary and guideline tracking and analysis can never be a “one size fits all” process. Our dedicated team of analysts work alongside you to advise and craft a methodology, approach and visualisation that delivers the insight and outputs you require.

Accessible via a single sign in, and fully synchronised to your Discovery 3.0 dashboard, Discovery Fx leads the way in real-time formulary and guideline analysis.

For the ultimate intelligence package, simply add Discovery Rx and unlock the ability to truly understand how formulary and guideline positioning and adherence is impacting prescribing activity.

All of your local insights, Rx data and formulary tracking and analysis fully synchronised and accessible via a single dashboard.


Understanding complex formulary data made simple


Fully synchronised with your Discovery 3.0 dashboard – no need for multiple sign-ins

Fully synchronised with Discovery Rx for simultaneous formulary and Rx data analysis

Data monitored and updated in real-time by our Analysts

100% customised. Outputs, displays and methodology – see your data, your way

Live tech support, unlimited training and proactive account management – as standard

Segment your market by position, restrictions, access and adherence + bespoke metrics

Instantly generate customised reports, comparisons and visualise historical data

Identify opportunity, risk, adherence and value using the Discovery Matrix